Grateful for Our Global Partners at MEDICA 2025
Viasonix would like to thank all of our many distributors and business partners who took the time to visit our booth at MEDICA 2025 in Düsseldorf. Your visit, your feedback, and your trust turned this year’s exhibition into a real success for our team.
Over four days, from November 17–20, 2025, MEDICA once again brought together the global medical technology community at Messe Düsseldorf.
For us, those days were all about meeting you in person, listening to your needs, and showing how Viasonix solutions can support better vascular and neurological care worldwide.
Viasonix at MEDICA: Falcon, Dolphin and New Innovations
At MEDICA 2025, we presented our two leading product lines alongside exciting upcoming solutions:
-
The Falcon family of peripheral vascular physiologic systems, used for segmental blood pressures, ABI, TBI, Doppler, PVR, PPG and stress testing in vascular labs and clinics.
-
The Dolphin Transcranial Doppler (TCD) product line, designed to measure cerebral blood flow in Neurology, ICU, and Neurosurgery settings.
You could explore the full Falcon line at our booth, including the flagship Falcon/PRO, which offers advanced physiologic diagnostics with multiple pressure channels, PVR, PPG, and Doppler options, all supported by powerful reporting and connectivity.
On the TCD side, our Dolphin systems – including all-in-one solutions such as Dolphin/MAX – demonstrated how non-invasive, real-time cerebral hemodynamics can be integrated into daily practice for stroke, vasospasm, sickle cell disease, intraoperative monitoring, and more.
In addition, we were proud to present:
-
VDop – our upcoming vascular Doppler innovation (pre-launch).
-
Falcon/Lite – a new addition to the Falcon family, designed to make advanced vascular diagnosis more accessible (pre-launch).
-
LiteWalk, our pneumatic foot compression device that mimics natural walking to support blood flow at home, ideal for elderly and post-surgery patients.
Together, these systems reflect our clear focus: delivering practical, high-end tools that help clinicians improve vascular and cerebral blood flow assessment in real-world settings.
Meeting Distributors from Five Continents
MEDICA is widely recognized as one of the world’s leading trade fairs for medical technology, healthcare IT, and diagnostics, attracting thousands of exhibitors and around 80,000 professional visitors from more than 160 countries each year.
For Viasonix, this huge international turnout is the perfect setting to reconnect with our distributors and partners from Europe, North America, Asia, and Latin America. This year was no exception.
Throughout the four days, the activity around the Viasonix booth was constant:
-
Back-to-back meetings with existing distributors.
-
Live demonstrations of Falcon vascular studies and Dolphin TCD monitoring.
-
Hands-on sessions with LiteWalk and our upcoming vascular solutions.
-
Discussions about regulatory approvals, training, and local marketing plans.
The level of interest and the quality of the conversations exceeded our expectations. Based on your feedback and the many opportunities discussed, we are confident that 2026 will bring even stronger growth and more patients benefiting from Viasonix technology.
Dr. Dan Manor, President and CEO of Viasonix, summed up the event with a clear message of gratitude and pride:
“We can’t thank enough our numerous distributors that visited our booth. Our many visitors spanned from South America to East Asia, and it is always surprising and exciting for us to see how people from different cultures, languages and environments unite so easily around our advanced Dolphin TCD and Falcon vascular products.
We are fortunate to have the international partners that we have, and express a big THANK YOU to all those that visited us at MEDICA this year. Viasonix has become a significant global hub for Transcranial Doppler and Peripheral Vascular Diagnostic systems, and we are happy to serve the international markets and community.”
Looking Ahead to Medica 2026
As MEDICA 2025 comes to a close, we’re filled with gratitude and excitement for what’s ahead. The inspiring conversations, valuable feedback, and shared vision with our global partners reaffirm our commitment to continuous innovation in vascular and neurovascular diagnostics.
We look forward to seeing you again at MEDICA 2026 and to another successful year of collaboration and growth.
For more information, please leave us a message.
